Distinct sets of genetic alterations in melanoma Journal Article


Authors: Curtin, J. A.; Fridlyand, J.; Kageshita, T.; Patel, H. N.; Busam, K. J.; Kutzner, H.; Cho, K. H.; Aiba, S.; Bröcker, E. B.; LeBoit, P. E.; Pinkel, D.; Bastian, B. C.
Article Title: Distinct sets of genetic alterations in melanoma
Abstract: BACKGROUND: Exposure to ultraviolet light is a major causative factor in melanoma, although the relationship between risk and exposure is complex. We hypothesized that the clinical heterogeneity is explained by genetically distinct types of melanoma with different susceptibility to ultraviolet light. METHODS: We compared genome-wide alterations in the number of copies of DNA and mutational status of BRAF and N-RAS in 126 melanomas from four groups in which the degree of exposure to ultraviolet light differs: 30 melanomas from skin with chronic sun-induced damage and 40 melanomas from skin without such damage; 36 melanomas from palms, soles, and subungual (acral) sites; and 20 mucosal melanomas. RESULTS: We found significant differences in the frequencies of regional changes in the number of copies of DNA and mutation frequencies in BRAF among the four groups of melanomas. Samples could be correctly classified into the four groups with 70 percent accuracy on the basis of the changes in the number of copies of genomic DNA. In two-way comparisons, melanomas arising on skin with signs of chronic sun-induced damage and skin without such signs could be correctly classified with 84 percent accuracy. Acral melanoma could be distinguished from mucosal melanoma with 89 percent accuracy. Eighty-one percent of melanomas on skin without chronic sun-induced damage had mutations in BRAF or N-RAS; the majority of melanomas in the other groups had mutations in neither gene. Melanomas with wild-type BRAF or N-RAS frequently had increases in the number of copies of the genes for cyclin-dependent kinase 4 (CDK4) and cyclin D1 (CCND1), downstream components of the RAS-BRAF pathway. CONCLUSIONS: The genetic alterations identified in melanomas at different sites and with different levels of sun exposure indicate that there are distinct genetic pathways in the development of melanoma and implicate CDK4 and CCND1 as independent oncogenes in melanomas without mutations in BRAF or N-RAS. Copyright © 2005 Massachusetts Medical Society.
Keywords: signal transduction; adolescent; adult; controlled study; preschool child; aged; aged, 80 and over; middle aged; gene mutation; major clinical study; mutation; diagnostic accuracy; ultraviolet radiation; melanoma; skin defect; sun exposure; skin neoplasms; risk factors; radiation exposure; chromosome aberration; dna; 1-phosphatidylinositol 3-kinase; pten phosphohydrolase; dna, neoplasm; genome; mutation rate; genes, ras; nucleic acid hybridization; cyclin d1; ultraviolet rays; disease predisposition; mitogen-activated protein kinases; b raf kinase; environmental exposure; genomic dna; genome, human; proto-oncogene proteins b-raf; cyclin dependent kinase 4; cyclin dependent kinase 1; cyclin-dependent kinase 4; hypothesis; light exposure; oncogene n ras
Journal Title: New England Journal of Medicine
Volume: 353
Issue: 20
ISSN: 0028-4793
Publisher: Massachusetts Medical Society  
Date Published: 2005-11-17
Start Page: 2135
End Page: 2147
Language: English
DOI: 10.1056/NEJMoa050092
PUBMED: 16291983
PROVIDER: scopus
DOI/URL:
Notes: --- - "Cited By (since 1996): 679" - "Export Date: 24 October 2012" - "CODEN: NEJMA" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Klaus J Busam
    688 Busam